Neurodegeneration: MicroRNA

microRNAs (miRNAs) are key regulatory RNAs that control modulate gene expression in various biological processes and neurodegenerative disorders. Here are the latest discoveries pertaining to miRNAs and neurodegeneration.

June 20, 2020

Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients

Multiple Sclerosis and Related Disorders
Seyyed Reza MousaviBabak Emamalizadeh
June 7, 2020
Review
Open Access

Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration

International Journal of Molecular Sciences
Floriana VolpicelliUmberto di Porzio
June 7, 2020
Review

Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers

Journal of Neurology
Gina FerrazzanoAntonella Conte
June 1, 2020

In Vitro Direct Reprogramming of Mouse and Human Astrocytes to Induced Neurons

Methods in Molecular Biology
Katerina Aravantinou-Fatorou, Dimitra Thomaidou
June 12, 2020
Review

GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells

Biochimica Et Biophysica Acta. Molecular Cell Research
Przemysław DudaJames A McCubrey
June 3, 2020
Open Access

Hypoxia-Induced miR-675-5p Supports β-Catenin Nuclear Localization by Regulating GSK3-β  Activity in Colorectal Cancer Cell Lines

International Journal of Molecular Sciences
Laura SaievaAlice Conigliaro
June 3, 2020
Review
Open Access

Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases

Cells
Albin JohnP Hemachandra Reddy
June 27, 2020
Open Access

Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Hye Jin HeoChi Dae Kim
June 4, 2020

Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson's disease via activating NF-κB signaling

The Kaohsiung Journal of Medical Sciences
Rui-Xian XingYan Cheng
June 19, 2020
Open Access

MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

Biomolecules
Janne M ToivonenInmaculada Martín-Burriel
June 25, 2020

Astrocyte-Derived Exosomes in an iPSC Model of Bipolar Disorder

Advances in Neurobiology
D AttiliK S O'Shea
May 30, 2020

Regulatory Role of MicroRNAs in Brain Development and Function

Advances in Experimental Medicine and Biology
Christos Yapijakis

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neurodegeneration-microrna/f60c606d-137a-42d7-b5fe-8ce5ed81795f